Although heterozygous GPVs in five FA genes (BRCA1, BRCA2, PALB2, BRIP1, or RAD51C) confer high/moderate BC/OC risk, we found no association between FANCG GPVs and BC/OC risk. This evidence concerns the gene BRCA2 and breast cancer.